How do you decide whether or not to give immunotherapy in patients with a history of an isolated, severe autoimmune event?

This challenging but very relevant question brings up a very common general scenario that the patient/clinician team find themselves – between the rock and a hard place or as the Odyssean story of Scylla and Charybdis so colorfully illustrated with Scylla as a six-headed monster who lived on a rock ...